浏览全部资源
扫码关注微信
1.中国科学院大学深圳医院药学部,广东 深圳 518107
2.佛山市妇幼保健院药剂科,广东 佛山 528000
3.广州市众为生物科技股份有限公司,广州 510010
主任药师,教授,博士生导师,博士。研究方向:生化药理、新药研发。电话:0755-27548785。E-mail:lrb90927@126.com
纸质出版日期:2023-10-30,
收稿日期:2023-04-21,
修回日期:2023-09-08,
扫 描 看 全 文
李茹冰,李伟达,刘文婷等.猪源纤维蛋白贴配方的优化 Δ[J].中国药房,2023,34(20):2497-2501.
LI Rubing,LI Weida,LIU Wenting,et al.Optimization of the formulation of a porcine fibrin patch[J].ZHONGGUO YAOFANG,2023,34(20):2497-2501.
李茹冰,李伟达,刘文婷等.猪源纤维蛋白贴配方的优化 Δ[J].中国药房,2023,34(20):2497-2501. DOI: 10.6039/j.issn.1001-0408.2023.20.09.
LI Rubing,LI Weida,LIU Wenting,et al.Optimization of the formulation of a porcine fibrin patch[J].ZHONGGUO YAOFANG,2023,34(20):2497-2501. DOI: 10.6039/j.issn.1001-0408.2023.20.09.
目的
2
优化猪源纤维蛋白贴(简称“DBT”)的配方。
方法
2
在单因素实验的基础上,以冻干前的纤维蛋白原、凝血酶和胶原蛋白含量为考察因素,以黏合强度、持黏力和吸水力的总评归一化(OD)值为响应值,采用Box-Behnken-响应面法优化DBT的配方,并进行验证。
结果
2
根据单因素实验和Box-Behnken-响应面法优化结果,结合实际生产,得DBT的最优配方为纤维蛋白原含量6.5 mg/cm
2
、凝血酶含量8.0 IU/cm
2
、胶原蛋白含量5.6 mg/mL;3次验证实验的平均OD值为0.726 6(RSD=0.58%,
n
=3),与预测OD值(0.733 0)的相对误差为-0.87%。
结论
2
所得DBT的最优配方稳定、可行。
OBJECTIVE
2
To optimize the formulation of a porcine fibrin patch (abbreviated as “DBT”).
METHODS
2
Based on single-factor tests, with the contents of fibrinogen, thrombin and collagen before freeze-drying as the factors, with the overall desirability (OD) value of adhesion strength, holding viscosity and water absorption as response value, the formulation of DBT was optimized by Box-Behnken-response surface methodology, and the verification tests were conducted.
RESULTS
2
According to the results of the single factor tests and Box-Behnken-response surface methodology, combined with the actual production, the optimal formulation of DBT was 6.5 mg/cm
2
of fibrinogen, 8.0 IU/cm
2
of thrombin and 5.6 mg/mL of collagen. The average OD value of 3 validation tests was 0.726 6 (RSD=0.58%,
n
=3), and the relative error of which with the predicted value (0.733 0) was -0.87%.
CONCLUSIONS
2
The optimal formulation of DBT is stable and feasible.
猪源纤维蛋白贴配方优化纤维蛋白原凝血酶胶原蛋白Box-Behnken-响应面法
formulation optimizationfibrinogenthrombincollagenBox-Behnken-response surface methodology
曾奇峰,陈谊. 纤维蛋白粘合剂的功能和对皮肤软组织修复的影响[J]. 粘接,2023,50(3):25-29.
ZENG Q F,CHEN Y. Hemostatic function of fibrin adhesive and its effect on skin and soft tissue repair[J]. Adhesion,2023,50(3):25-29.
LITVINOV R I,PIETERS M,DE LANGE-LOOTS Z,et al. Fibrinogen and fibrin[J]. Subcell Biochem,2021,96:471-501.
STERGIOS K,FROUNTZAS M,PERGIALIOTIS V,et al. The effect of TISSEEL® on colorectal anastomosis hea-ling process in a diabetic animal experimental model[J]. In Vivo,2020,34(2):659-665.
朱浩方,毛宏理,顾忠伟. 医用组织粘合剂的研究进展[J]. 中国材料进展,2020,39(增刊1):535-550,557.
ZHU H F,MAO H L,GU Z W. Medical tissue adhesives:research progress[J]. Mater China,2020,39(Suppl 1):535-550,557.
李伟达,邓乐君,朱晋辉,等. 猪源纤维蛋白贴对大鼠肝脏及肝素化兔臀大肌创面的止血作用[J]. 中国药房,2017,28(28):3911-3914.
LI W D,DENG L J,ZHU J H,et al. Study on the hemostatic effect of porcine fibrin sealant patch on bleeding wound of liver in rats and gluteus maximus in heparinized rabbits[J]. China Pharm,2017,28(28):3911-3914.
HOFFMANN G A,WONG J Y,SMITH M L. On force and form:mechano-biochemical regulation of extracellular matrix[J]. Biochemistry,2019,58(47):4710-4720.
OKAMURA H. Sutureless repair techniques for post-infarction left ventricular free wall rupture[J]. Ann Cardiothorac Surg,2022,11(3):268-272.
ROMERO-VELEZ G,KABAN J M,CHAO E,et al. Use of the EVARREST patch for penetrating cardiac injury[J]. Trauma Case Rep,2020,28:100324.
LIPITSÄ T,SIISKONEN H,NAUKKARINEN A,et al. Mast cell chymase degrades fibrinogen and fibrin[J]. Br J Dermatol,2019,181(2):296-303.
LUYENDYK J P,SCHOENECKER J G,FLICK M J. The multifaceted role of fibrinogen in tissue injury and inflammation[J]. Blood,2019,133(6):511-520.
FELLER T,CONNELL S D A,ARIЁNS R A S. Why fibrin biomechanical properties matter for hemostasis and thrombosis[J]. J Thromb Haemost,2022,20(1):6-16.
骆井万,范海明,刘畅,等. 可注射封闭性水凝胶力学性质与其止血性能的相关性[J]. 医用生物力学,2020,35(4):496-501.
LUO J W,FAN H M,LIU C,et al. The correlation between mechanical properties and hemostatic ability of injectable sealing hydrogels[J]. J Med Biomech,2020,35(4):496-501.
国家药典委员会. 中华人民共和国药典:四部[M]. 2020年版. 北京:中国医药科技出版社,2020:143-145.
Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia:part Ⅳ[M]. 2020 edition. Beijing:The Medicine Science and Technology Press of China,2020:143-145.
张玖捌,张伟,王彬,等. 基于Box-Behnken响应面法的白芍产地加工与炮制生产一体化工艺研究[J]. 中草药,2022,53(18):5657-5662.
ZHANG J B,ZHANG W,WANG B,et al. Study on integrated process of producing area and processing production for Paeoniae Radix Alba based on Box-Behnken response surface methodology[J]. Chin Tradit Herb Drugs,2022,53(18):5657-5662.
黄光强,郑飘雪,梁洁,等. Box-Behnken响应面法结合多指标综合评分法优化龙眼叶提取工艺[J]. 中国药房,2022,33(14):1688-1693.
HUANG G Q,ZHENG P X,LIANG J,et al. Optimization of the extraction technology of the leaves of Dimocarpus longan by Box-Behnken response surface methodology combined with multi-index comprehensive score[J]. China Pharm,2022,33(14):1688-1693.
HE S,WALLÉN H,THÅLIN C,et al. Fibrin network porosity and endo-/exogenous thrombin cross-talk[J]. Semin Thromb Hemost,2021,47(7):775-786.
0
浏览量
3
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构